Veeva Systems Inc.
TypePublic benefit corporation
IndustrySoftware for life sciences
Founded2007; 19 years ago (2007)
Founders
Headquarters
United States Edit this on Wikidata
Key people
ProductsSoftware
ServicesBusiness consulting
RevenueIncrease US$3.195 billion (FY 2026)
Increase US$916 million (FY 2026)
Increase US$908 million (FY 2026)
Total assetsIncrease US$8.979 billion (FY 2026)
Total equityIncrease US$7.214 billion (FY 2026)
Number of employees
7,928 (2026)
Websiteveeva.com
Footnotes
[1][2]

Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry.[1] Its products are used to track all aspects of drug development and pharmaceutical manufacturing.[1]

The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia.[1] Its primary competitor for its customer relationship management software is Salesforce, which is partnered with IQVIA.[1]

History

Veeva was founded in 2007 by Peter Gassner and Matt Wallach.[2]

In 2011, the company introduced Veeva Vault, a content management system for the life sciences industry.[3]

In October 2013, Veeva became a public company via an initial public offering on the New York Stock Exchange.[4][5]

In February 2021, Veeva became the first publicly traded company to convert to a public benefit corporation.[6]

In 2025, Veeva ended its partnership with Salesforce, a competitor.[7]

Acquisitions

# Date Company Notes Ref.
1 October 2015 Zinc Ahead Content management software company [8]
2 October 2019 Crossix Medical privacy-safe patient data and analytics company [9]
3 November 2019 Physicians World Provider of business process outsourcing services [10]
4 August 2021 Learnaboutgmp Compliance training services for life sciences organizations [11]
5 December 2021 Veracity Logic Provider of cloud software for randomization and trial supply management [12]
6 March 2026 Ostro Patient and HCP engagement with AI agents for life sciences; price was $100 milllion [13]

References

  1. ^ a b c d e "Veeva Systems, Inc. Annual Report fiscal year ending January 31, 2026 (Form 10-K)". U.S. Securities and Exchange Commission. March 20, 2026.
  2. ^ a b "Peter Gassner Profile". Forbes.
  3. ^ "Veeva Systems Introduces New Regulated Content Management Solution for Life Sciences" (Press release). February 15, 2011 – via Biospace.
  4. ^ Gage, Deborah (October 16, 2013). "Veeva Systems Soars in IPO In Win For Biotech Cloud Software". The Wall Street Journal.
  5. ^ Aggarwal, Varun; Das, Avik (October 16, 2013). "Cloud company Veeva's shares nearly double in debut". Reuters.
  6. ^ Rinker, Brian (January 27, 2021). "Veeva Systems is now a public benefit corporation. But what does that mean?". American City Business Journals.
  7. ^ Ford, Brody (December 24, 2024). "Salesforce Stokes Veeva Fight by Snagging Drug Customers". Bloomberg Law.
  8. ^ "Veeva scoops up rival Zinc Ahead to create mega-content management platform". Fierce Pharma (Press release). Questex. October 5, 2015.
  9. ^ Bulik, Beth Snyder (October 2, 2019). "Veeva acquires Crossix, pairing doctor, patient data and marketing services". Fierce Pharma. Questex.
  10. ^ "Veeva Acquires Physicians World" (Press release). Business Wire. November 7, 2019.
  11. ^ "Veeva Systems Inc. acquired Learnaboutgmp LLC". S&P Global. August 2, 2021.
  12. ^ "Veeva Systems Inc. acquired Veracity Logic, LLC". S&P Global. December 12, 2021.
  13. ^ Park, Andrea (March 11, 2026). "Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement". Fierce Pharma. Questex.
  • Official website
  • Business data for Veeva Systems Inc.: